(ÁÖ)¸°ÀÎÆÄÆ®³Ê½º
[¾÷°è¿ì´ë/¼º°ú±ÞÁ¦°ø ]
T cell engager(ÀÌÁßÇ×ü/TCE) ÇÁ·ÎÁ§Æ® ¸®´õ(½Ç¹«Ã¥ÀÓÀÚ±Þ)
T¼¼Æ÷ ¼ö¿ëü(TCR) ±â¼úÀ» ÀÌ¿ëÇÑ ¸é¿ª¼¼Æ÷Ä¡·áÁ¦ ¹× Ç×üġ·áÁ¦¸¦ °³¹ßÇÏ´Â ±â¾÷,
A ÅõÀÚ ¶ó¿îµå¿¡¼ ¾à 280¾ï ¿øÀÇ ÀÚ±Ý À¯Ä¡, ¼ºÀå °¡´É¼ºÀÌ ³ôÀº ȸ»ç ÀÔ´Ï´Ù.
´Ù¾çÇÑ Ç×¾Ï Ä¡·áÁ¦ °³¹ß(±â¼úÀÌÀü °è¾à Á¦°á ¿Ï·á)
**Ÿ°Ù Áúȯ :Æó¾Ï, °íÇü¾Ï µî * KPI¿¡ µû¸¥ ¼º°ú±ÞÁö±Þ, ¾÷°è¿ì´ë
¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç
| ¸ðÁýºÎ¹® | ´ã´ç¾÷¹« | ÀÚ°Ý¿ä°Ç | Àοø | |
|---|---|---|---|---|
| T cell engager(ÀÌÁßÇ×ü/TCE) ÇÁ·ÎÁ§Æ® ¸®´õ(½Ç¹«Ã¥ÀÓÀÚ±Þ) |
[´ã´ç¾÷¹«] - T cell engager(TCE) ¼³°è ÁÖµµ: Ÿ±ê/Æ÷¸Ë(¿¹: 2+1 µî)°ËÅä, construct design, Èĺ¸ ¼³°è ¹æÇâ ¼ö¸³ ¹× °³¼± CRO¸¦ Ȱ¿ëÇÑ ¸µÄ¿-ÆäÀ̷εå conjugation ¾÷¹« |
[ÀÚ°Ý¿ä°Ç] • °æ·Â 3³â ÀÌ»ó ~6³â [¿ì´ë»çÇ×] - ´Ù¾çÇÑ TCE Æ÷¸Ë/±âÀü ºñ±³(affinity tuning, CD3 arm ¼³°è/¾ÈÀü¼º °í·Á µî) °æÇè - MOA °íµµÈ °æÇè(¿¹: phospho-flow, activation signaling, ¸é¿ª½Ã³À½º/engagement Á¤·®, target density-dependent activity µî) - Cytokine release/over-activation risk °üÁ¡ÀÇ in vitro ¾ÈÀü¼º Æò°¡ °æÇè - ³í¹®/ƯÇã µî ¿¬±¸ ¼º°ú º¸À¯ - ¹Ú»ç±Þ ¿ì´ë |
0 ¸í |
¹®ÀÇ »çÇ× ******@*******.*** ¶Ç´Â ***-****-**** °¹ÎÁ¤ºÎÀåÀ¸·Î ¿¬¶ô ºÎʵ右´Ï´Ù.
±Ù¹«Á¶°Ç
ÀüÇü´Ü°è ¹× Á¦Ãâ¼·ù
Á¢¼ö¹æ¹ý
ä¿ë½Ã
±âŸ À¯ÀÇ»çÇ×
00